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Unprecedented Mechanism of Chain
Length Determination in Fungal
Aromatic Polyketide Synthases
with a KS. This KS-CLF complex, together with an acyl
carrier protein (ACP) and a malonyl-CoA:ACP transacy-
lase, makes up a so-called minimal PKS. Chain length
of the type II PKS products is determined by this minimal
PKS. The first ring of the product is formed in the minimal
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PKS reaction and discrete cyclases catalyze further cy-
clizations. Recently, the KS-CLF complex has been
shown to possess decarboxylation activity toward malo-Summary
nyl-ACP as well to provide acetyl-ACP required to prime
chain extension [5]. Plant and bacterial type III PKSs,Fungal aromatic polyketides show remarkable struc-
which produce aromatic polyketides such as precursorstural diversity fundamentally derived from variations
of flavonoids and vancomycin, are homologous to Esch-in chain length and cyclization pattern. Their basic
erichia coli KS III. The crystal structure of plant chalconeskeletons are synthesized by multifunctional iterative
synthase (CHS) has been elucidated [6], and the engi-type I polyketide synthases (PKSs). Recently, we have
neering of CHS based on that structural knowledge hasfound that the C-terminal thioesterase (TE)-like do-
demonstrated that the space of the active site cavitymain of Aspergillus nidulans WA catalyzes Claisen-
restricts product size [7]. However, compared with planttype cyclization to form the B-ring of naphthopyrone
and bacterial PKSs, the mechanism of reactions cata-YWA1. Here we report the unprecedented mechanism
lyzed by fungal iterative type I PKSs is still unclear.of chain length determination by the C-terminal TE-like
Fungal iterative type I aromatic PKSs are divided intodomain of Colletotrichum lagenarium PKS1, which, in
two groups based on domain architecture (Figure 1A):addition to catalyzing Claisen-type cyclization, inter-
the MSAS-type such as Penicillium patulum MSAS [8]cepts the polyketomethylene intermediate from the
and Aspergillus terreus ATX [9], and the WA-type suchacyl carrier protein domain during the condensation
as Aspergillus nidulans WA [10] and Colletotrichum la-reaction to produce shorter chain length products.
genarium PKS1 [11]. WA-type PKSs characteristicallyThis chain length determination system is novel
have an N-terminal extended domain (domain A), a cen-among PKSs, including bacterial and plant PKSs. The
tral domain (domain B), and a C-terminal TE-like domain.functional diversity of the TE-like domain directly influ-
Domain A and domain B have no homology to any otherences the structural diversity of aromatic polyketides
known functional proteins and their functions are stillin C. lagenarium PKS1.
unknown. On the other hand, we have recently demon-
strated that the C-terminal TE-like domain of A. nidulans
Introduction WA functions as a Claisen cyclase (CLC) that catalyzes
Claisen cyclization of the B-ring of heptaketide YWA1
The polyketides are an important group of natural prod- [12, 13] (Figure 1B). When the WA CLC domain is inacti-
ucts and a source of biologically active compounds. vated, the B-ring is formed by nonenzymatic lactonization
Polyketides are synthesized from several acyl units by to produce heptaketide isocoumarin [14]. As other WA-
polyketide synthases (PKSs), which catalyze successive type PKSs such as C. lagenarium PKS1 also produce
condensation reactions of acyl-CoAs, mostly acetyl- and Claisen cyclization-type compounds, the C-terminal TE-
malonyl-CoAs, to produce polyketomethylene interme- like domains of other WA-type PKSs are also expected
diates and some subsequent reactions such as cycliza- to function as Claisen cyclases.
tion and reduction of the intermediates. PKSs are sepa- C. lagenarium PKS1 also has domain architecture
rated into three types: type I [1, 2], type II [3], and type identical to that of WA, although PKS1 produces multiple
III [4] PKSs. Type I PKSs are further divided into two products, i.e., tetraketide orsellinic acid, pentaketide
classes: modular type I PKSs and iterative type I PKSs.
-acetylorsellinic acid, pentaketide tetrahydroxynaph-
Many investigations have been carried out to demon- thalene (THN) [15], and an unknown compound when
strate how PKSs control reactions such as chain length heterologously expressed in Aspergillus oryzae, unlike
determination in plant and bacterial PKSs. Bacterial WA that specifically produces the heptaketide YWA1
modular type I PKSs, which produce macrolides such under the same heterologous expression condition. The
as erythromycin, are composed of several modules that production of -acetylorsellinic acid suggests that the
each catalyze a single condensation step. In modular C-terminal TE-like domain of PKS1 catalyzes the hydro-
PKSs, the product chain length is determined depending lysis of an ACP-bound pentaketide intermediate as well
on the number of modules, and the product is lactonized as Claisen-type cyclization, unlike the WA CLC domain.
by thioesterase (TE) domains. Bacterial type II PKSs, Furthermore, we have recently reported that a chimeric
which produce polycyclic aromatic polyketides such as PKS, SW-B, produces hexaketides as major products
tetracycline, are composed of an assembly of discrete [16], while wild-type PKS1 produces pentaketides as
enzymes. A chain length factor (CLF), which is homolo- major products. As SW-B is a PKS1 derivative in which
gous to a -ketoacylsynthase (KS), forms a heterodimer the ACP and C-terminal TE-like domains are replaced
with those of WA and there is no evidence that ACP
controls the product chain length, the C-terminal TE-*Correspondence: yebiz@mol.f.u-tokyo.ac.jp
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Figure 1. C-Terminal Domains of Fungal PKSs
(A) Domain architecture of WA-type PKSs and
MSAS-type PKSs. KS, -ketoacylsynthase;
AT, acyltransferase; ACP, acyl carrier protein;
CLC, Claisen-type cyclase; KR, -ketoacyl
reductase; DH, dehydratase.
(B) Claisen cyclization of the B-ring of YWA1
by the WA CLC domain.
like domain seems to be involved in the control of the Ser2009 that corresponds to the active Ser site of WA
CLC was mutated to Ala.product chain length in PKS1.
In this investigation to elucidate the function of the
C-terminal TE-like domain of PKS1, PKS1 mutants on Results
the C-terminal TE-like domain, PKS1-dC, and PKS1-
S2009A were constructed (Figure 2A). PKS1-dC is a Transformation
Expression plasmids pTA-pks1-dC and pTA-pks1-S2009AC-terminal TE-like domain-deletion mutant. PKS1-S2009A
is a site-directed mutant of PKS1, in which the original were constructed to express PKS1-dC and PKS1-A2009A,
Figure 2. Product Identification of Wild-Type
PKS1 and Its Mutants
The proportion of each compound is shown
as the percentage in the total of products.
(A) PKS1 mutants. (B) Products of wild-type
PKS1. (C) Products of PKS1-dC and PKS1-
S2009A. ATHN, 2-acetyl-1,3,6,8-tetrahydroxy-
naphthalene; THN, tetrahydroxynaphthalene.
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Figure 3. Effect of the CLC Domain on Chain
Length
The black bar shows the part derived from
PKS1 and the white bar shows that derived
from WA. The length of bars indicates the
percentage in the total of products.  CLC,
wild-type in which the CLC domain is
active; CLC, mutant in which the CLC do-
main is inactive; Tetra, tetraketide; Penta,
pentaketide; Hexa, hexaketide; Hepta, hep-
taketide. (A) PKS1; (B) WA; (C) SW-B.
respectively. These expression plasmids were introduced of PKS1, the CLC domain mutants specifically produce
into A. oryzae M-2-3 to obtain transformants A.o/pTA- a hexaketide, while the wild-type in which the CLC do-
pks1-dC and A.o/pTA-pks1-S2009A. main is active produces pentaketides as major products
The transformants with PKS1-dC or PKS1-S2009A (Figure 3A). This indicates that PKS1 potentially has the
formed white colonies, while transformants with wild- capacity to synthesize hexaketides but that the active
type PKS1 formed dark brown colonies. CLC domain interferes with chain length growth.
Product Identification of Wild-Type PKS1 Product Identification of a CLC Domain
As a result of liquid chromatography-electrospray ion- Mutant of SW-B
ization-mass spectrometry (LC-ESIMS) analysis of the Unlike PKS1-dC, SW-B produces significant amounts
induction medium of the transformant with wild-type of pentaketides, indicating that the WA CLC domain in
PKS1, unknown compounds were identified as a hex- SW-B also shortens product chain length. To confirm
aketide 2-acetyl-1,3,6,8-tetrahydroxynaphthalene and this, we expressed SW-B-dC, which is a CLC domain-
its sulfate conjugate. The relative amounts of these deletion mutant of SW-B. The transformant with SW-
PKS1 products, estimated by the peak area in the high- B-dC specifically produced hexaketide isocoumarin,
performance liquid chromatography (HPLC) profile like PKS1-dC and PKS1-S2009A (Figure 3C). This con-
monitored by UV absorption at 254 nm, are shown in firms that the WA CLC domain also shortens product
Figure 2B. The HPLC profile shows that the pentaketide chain length when fused with PKS1, while it does not
synthase PKS1 also produces notable amounts of tetra- in wild-type WA.
ketide and hexaketide.
DiscussionProduct Identification of CLC Domain
Mutants of PKS1
The present results indicate that PKS1 potentially hasBoth transformants with PKS1-dC or PKS1-S2009A
the capacity to synthesize products as large as hexake-yielded an almost identical product pattern and predom-
tides but that the active CLC domain interferes withinantly synthesized a hexaketide isocoumarin (ca. 95%
chain length growth. To the best of our knowledge, noof total products) with a pentaketide isocoumarin (ca. 5%)
domains or components that interfere with chain lengthand only a trace amount of pentaketide -acetylorsel-
growth have been reported previously among the knownlinic acid (Figure 2C). The lack of production of Claisen
PKSs, including plant and bacterial PKSs.cyclization-type compounds and the predominance of
In the biosynthesis of short-chain fatty acids in ani-pentaketide isocoumarin over pentaketide -acetyl-
mals, the monofunctional thioesterase TE II has beenorsellinic acid in these mutants indicate that the CLC
reported to be responsible for the chain shortening ofdomain of PKS1 catalyzes the hydrolysis of ACP-bound
C16 acid to C10–C14 acids [17, 18]. By interacting withthioesters as well as Claisen-type cyclization unlike the
type I fatty acid synthase, which normally synthesizesCLC domain of WA. The most striking result, however,
C16 acid, TE II hydrolyzes shorter fatty acyl intermedi-was that the chain length of the products varied mark-
ates during condensation cycles. The CLC domain ofedly depending on the presence or absence of the active
PKS1, like TE II, is assumed to intercept the polyketo-C-terminal CLC domain.
methylene intermediate from the ACP halfway through
the condensation reaction, and Ser2009 must play anEffect on Product Chain Length
important role in chain shortening.of the CLC Domain
As the CLC domain-deletion mutants of WA and PKS1In the case of WA, both the wild-type and CLC domain
specifically synthesize heptaketide and hexaketide iso-mutants specifically produce a heptaketide, which indi-
coumarins, respectively, it is obvious that the chaincates that the WA CLC domain is not involved in product
chain length (Figure 3B). On the other hand, in the case shortening by the CLC domain of PKS1 is not an essen-
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Figure 4. Proposed Mechanism of Chain
Length and A-Ring Cyclization Controls
(A) CLC domain-inactivated mutants of PKS1.
(B) Wild-type PKS1 where the CLC domain is
active.
tial but an additional system controlling chain length, could be a reversible process, allowing the intermediate
to be transferred back to the ACP domain and enter theand that the fundamental chain length control and for-
mation of the A-ring must be carried out by other do- cavity again. However, as the intermediate is a long and
flexible chain, it is caught within the inner wall of themains such as the KS domain. Interestingly, however,
A-ring cyclization of shorter chain intermediates, re- cavity and folded to form the A-ring. This results in the
production of shorter chain products.sulting from chain elongation intercept by the wild-type
PKS1 and SW-B, occurs between C-2 and C-7, a posi- In this mechanism, the question is why the shorter
intermediate is intercepted by the CLC domain in PKS1,tion identical to that for hexaketide isocoumarin synthe-
sis by the CLC domain-deletion mutant of PKS1. The but not intercepted in WA. A simple answer to this ques-
tion could be that the PKS1 CLC domain has high speci-polyketomethylene intermediate must be cyclized after
being intercepted by the CLC domain, but A-ring forma- ficity toward linear pentaketide intermediate, while the
WA CLC domain shows low specificity toward shortertion is unlikely to be catalyzed by the CLC domain, as
it is not an inherent function. linear intermediates. However, as shown in Figure 3C,
SW-B produces significant amount of pentaketide unlikeBased on the above evidence, we propose the follow-
ing mechanism to account for the chain length shorten- SW-B-dC, which indicates that the WA CLC domain
also interferes with chain length growth when fused withing exhibited by the CLC domain. In the case of PKS1-
dC (Figure 4A), the polyketomethylene intermediate PKS1, while it does not in the wild-type WA. This fact
suggests that the chain shortening function cannot begrows to fill the active site cavity formed within the KS
domain, and then A-ring cyclization occurs after the ascribed to the substrate specificity of the CLC domain
alone, but is highly dependent on its interaction withhexaketide intermediate is appropriately folded. In the
case of wild-type PKS1 (Figure 4B), the shorter polyketo- other domains such as the KS and ACP. In the case of
PKS1, the active site Ser residue of the CLC domain ismethylene (pentaketide) intermediate is transferred from
the ACP domain to the CLC domain before the final assumed to be positioned near the ACP-bound thioester
during the condensation reaction, while it is not in WA.condensation and pulled out of the cavity. This transfer
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gous fungus A. oryzae M-2-3, which is an arginine auxotrophic mu-In the case of SW-B, the WA CLC domain is assumed
tant produced using the protoplast-polyethylene glycol methodto interact with ACP-bound thioester during the conden-
[23, 24].sation reaction less efficiently than the PKS1 CLC do-
main in PKS1. It is probable that the substrate specificity Expression of PKSs
of the CLC domain itself toward linear intermediate also The transformants were selected on minimal agar plates. After pre-
influences the ratio of shorter chain products. Further culture for 4 days, the transformants were shake cultured, first in
Czapek-Dox medium supplemented with glucose for 4 days andexperimental data including kinetic ones would clarify
then in Czapek-Dox medium supplemented with starch for inductionthis interesting issue.
for 1 additional day. In the case of transformants with SW-B or SW-The results of this investigation also cast new light on
B-dC, expression was induced by shaking the culture in minimal
the biosynthesis of THN in fungi. THN is a precursor of medium supplemented with starch for induction for 1 additional day,
1,8-dihydroxynaphthalene-melanin, a well-known viru- after shaking the culture in Czapek-Dox medium supplemented with
lence factor of plant [19]- and human [20]-pathogenic glucose for 4 days. Product characterization of these mutants was
performed by LC-ESIMS analysis of the culture medium after in-fungi. In the human-pathogenic fungus Aspergillus fumi-
duction.gatus that causes pulmonary aspergillosis, THN is syn-
thesized by two discrete enzymes. ALB1 PKS, which
Construction of CLC Domain Mutant Genesshows high homology with WA, first synthesizes the
The pTA-pks1-dC was created by digesting the expression plasmid
heptaketide naphthopyrone from acetates, and then es- pTAPSG [15] with restriction enzyme SmaI (TaKaRa), followed by
terase-like AYG1 decomposes it into acetoacetate and self-ligation.
The pTA-pks1-S2009A was generated by site-directed mutagene-pentaketide THN [21, 22]. On the other hand, in the
sis using the PCR method. The PCR primers used were 5-CCGCCCphytopathogenic fungus C. lagenarium that causes an-
GCAGCCCAACCC-3, 5-CCACCAAGGAGATCAACACTC-3, andthracnose in cucurbitaceous plants, THN is directly syn-
5-TACGCGTCTAGAAGGAACGTGTTAGATTG-3. The PCR frag-thesized by the single enzyme PKS1. In the present
ment was subcloned into pT7 Blue vector to construct pT7-S2009A.
study, we have shown that PKS1 has the potential to The SmaI fragment of pT7-S2009A was replaced with the SmaI
synthesize hexaketide and its CLC domain intercepts fragment of pTAPSG to construct pTA-pks1-S2009A.
The pTA-sw-B-dC was created by digesting the pTA-sw-B withthe pentaketide intermediate from the ACP before the
restriction enzyme MluI (TaKaRa), followed by end blunting and self-final condensation reaction, resulting in the synthesis
ligation.of pentaketide THN. It is an intriguing question to ask
why these fungi use such complicated mechanisms to
Characterization of PKS Products
synthesize THN instead of producing the pentaketide Characterization of each PKS was performed using HPLC and LC-
directly and specifically. ESIMS analysis of the culture medium after induction. A reverse-
phase column (TOSOH ODS-80Ts, 4.6  150 mm) was eluted with
a linear gradient of 5%–40% CH3CN in 2% AcOH (aqueous solution)Significance over 30 min at a flow rate of 0.8 ml/min, with detection at 254
nm. The same LC conditions were employed for LC-ESIMS (LCQ,
The understanding of how PKSs control their PKS re- Thermo Quest) with negative ion monitoring. Chemical identification
was done by direct comparison with authentic samples.actions such as chain length determination is ex-
pected to contribute to the production through bio-
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